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Abstract
Germline mutations in the NF1 tumor suppressor gene cause neurofibromatosis type 1 (NF1), a complex genetic disorder
with a high predisposition of numerous skeletal dysplasias including short stature, osteoporosis, kyphoscoliosis, and fracture
non-union (pseudoarthrosis). We have developed murine models that phenocopy many of the skeletal dysplasias observed
in NF1 patients, including reduced bone mass and fracture non-union. We also show that the development of these skeletal
manifestations requires an Nf1 haploinsufficient background in addition to nullizygous loss of Nf1 in mesenchymal stem/
progenitor cells (MSCs) and/or their progenies. This is replicated in two animal models of NF1, PeriCre
+;Nf1
flox/2 and
Col2.3Cre
+;Nf1
flox/2mice. Adoptive transfer experiments demonstrate a critical role of the Nf1+/2 marrow microenvironment
in the impaired fracture healing in both models and adoptive transfer of WT bone marrow cells improves fracture healing in
these mice. To our knowledge, this is the first demonstration of a non-cell autonomous mechanism in non-malignant NF1
manifestations. Collectively, these data provide evidence of a combinatory effect between nullizygous loss of Nf1 in
osteoblast progenitors and haploinsufficiency in hematopoietic cells in the development of non-malignant NF1
manifestations.
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Introduction
Bone integrity is maintained by the balance between osteoclasts
originated from hematopoietic stem cells and mesenchymal-
derived osteoblasts. Osteoclasts are multinucleated cells specialized
in bone resorption, whereas osteoblasts are bone forming cells
derived from the mesenchymal stem cells. The development of the
osteoblast and osteoclast lineages is tightly coupled [1]. Imbalances
in coupling of the two lineages leads to defective skeletal
development [2] as well as abnormal hematopoiesis [3,4].
Mutations in the NF1 tumor suppressor gene cause neurofibro-
matosis type 1 (NF1), a common chronic debilitating disorder that
affects 1 in 3,000 individuals [5,6,7,8,9]. Neurofibromin, the
protein encoded by NF1, functions at least in part as a GTPase
activating protein (GAP) for Ras. Loss of heterozygosity of the
tumorigenic cell is required for genesis of tumors in individuals
with NF1 [10,11]. However, recent studies have also identified a
key role of the microenvironment in tumor progression in both
plexiform neurofibromas [12] and optic gliomas [13,14] in NF1.
Despite advances in understanding the cell-cell interactions in
cancers affecting NF1 patients, little information of the molecular
and cellular signaling of the microenvironment of the prevalent
nonmalignant manifestations of NF1 exists, particularly those
impacting the skeletal system that are prevalent in ,50% of NF1
patients [6,7,8,9,15,16,17,18,19,20]. Clinical studies have found
that individuals with NF1 are at significant risk for generalized loss
of bone mass (osteopenia and osteoporosis) [21,22,23,24,25,26] as
well as focal skeletal abnormalities [25,27,28,29]. One focal
skeletal abnormality, non-union of spontaneous fractures, also
called pseudoarthrosis, is particularly debilitating and frequently
affects the distal tibia. Despite a range of orthopedic procedures
attempting to facilitate fracture healing, the typical clinical
outcome is non-union of the fracture and ultimately amputation
of the affected limbs.
Skeletal development and remodeling depends on the balance
of interactions between osteoblasts-mesenchymal stem cell derived
cells, and osteoclasts-specialized macrophages derived from
hematopoietic stem cells that govern skeletal remodeling and
bone resorption [30]. We have previously shown that NF1 patients
and Nf1 haploinsufficient mice have elevated osteoclast activity
PLoS ONE | www.plosone.org 1 September 2011 | Volume 6 | Issue 9 | e24917[31]. However, the increase in lytic activity of osteoclasts alone is
not sufficient to explain some of the osseous manifestations
observed in the NF1 patients. Kolanczyk and colleagues observed
bowing of the tibia and diminished growth in Nf1
flox/flox mice that
express Prx1Cre, which is expressed in undifferentiated mesen-
chymal cells in the limb bud. While those studies were informative
concerning limb manifestations of the disease, the axial skeletal
(e.g. kyphosis) are not modeled well due to a lack of expression of
PrxCre in the vertebrae [32]. Elefteriou and colleagues utilized a
genetic approach to delete Nf1 in the osteoblast lineage by
intercrossing Nf1
flox/flox mice with a1(I) Collagen Cre transgenic
mice and found that Nf1 inactivation in osteoblasts affects
osteoclast differentiation in addition to bone formation [33,34].
In the present study, we utilized two novel murine models and
established that the hematopoietic microenvironment plays a
critical role in fracture healing in the NF1 murine models. Our
study provides strong evidence of a non-cell autonomous
mechanism for the skeletal manifestations of NF1 and demon-
strates that the hematopoietic microenvironment is instrumental
for bone loss and impaired fracture healing process.
Results
Detection of periostin expression in MSCs, osteoblasts,
and generation of PeriCre
+;Nf1
flox/2 mice
Endogenous full-length Periostin is expressed in primitive MSCs
and epithelial cells [35,36]. To confirm 3.9 kb Periostin fragment
promoter mediated Cre expression in adult MSCs and skeletal
tissues, PeriCre
+ mice were intercrossed with transgenic reporter
mice that have LacZ sequence knocked into the Rosa26 locus. The
skeletal tissues of the intercrossed progeny were then subjected to
b-gal staining. LacZ expression was abundant in the peripheral
nervous system as expected [37] but was also detected in
osteoblasts within the cartilaginous ribs as they begin the process
of ossification, the long bone, and vertebrae cartilage of adult
PeriCre
+;Rosa26
flox/flox mice (data not shown). However, LacZ
staining was not observed in PeriCre
2;Rosa26
flox/flox littermates
(Figure S1A, c, d). The expression of LacZ in bone tissue was
confirmed following LacZ staining and hematoxylin/eosin (H&E)
counterstaining (Figure S1A). Interestingly, LacZ expression
within MSCs and skeletal tissues was detected only in mice 4
weeks of age or older, as PeriCre activity is initially restricted to the
in utero heart valves, fetal and neonatal cardiac fibroblasts [38], and
peripheral nervous system (Snider & Conway, unpublished data).
Significantly, like the endogenous Periostin protein, Peri-Cre
reporter expression is robustly localized to both the postnatal
and adult outer periosteum, which gives rise to the bone collar
covering all skeletal elements, including cancellous bone, and
within the inner endosteal osteoblasts that secrete the vascularized
bone-specific matrix [39]. LacZ expression was also examined in
adult primary calvarial osteoblasts and MSCs in vitro following
culture in specialized medium that selectively promotes the growth
of these lineages. LacZ was strongly expressed in cultured adult
calvarial osteoblasts and ,15% of the cultured MSCs were LacZ
positive (Figure S1B, a, b).
PeriCre
+ mice were then intercrossed with mice bearing either
systemic or conditional genetic targeting of the Nf1 allele (Nf1+/2
and Nf1
flox/flox, respectively) to generate four experimental
genotypes: PeriCre
2;Nf1
flox/flox (control, referred to as WT mice),
PeriCre
2;Nf1
flox/2 (referred to as Nf1+/2), PeriCre
+;Nf1
flox/flox mice
(Nf1 null in MSCs and osteoblasts, otherwise systemically WT),
and PeriCre
+;Nf1
flox/2 mice (Nf1 null in MSCs and osteoblasts,
otherwise systemically Nf1 heterozygous). The offspring were
genotyped by PCR (Figure S2). The postnatal deletion of
neurofibromin protein was confirmed by western blot. A clear
gene dose-dependent reduction of neurofibromin was detected in
Nf1+/2 MSCs and osteoblasts as compared to their WT
counterparts and no neurofibromin was detected in adult Nf12/2
MSCs and osteoblasts (Figure S1C).
PeriCre
+;Nf1
flox/2 mice have reduced bone mineral
density (BMD) and bone volume
To evaluate whether the PeriCre
+;Nf1
flox/2 mouse model recapit-
ulatesthebonemanifestationsofNF1patients,wemeasuredskeletal
mass and density in the four experimental genotypes. PeriCre
+;
Nf1
flox/2 mice and PeriCre
+;Nf1
flox/flox micewereborn at the expected
Mendelian ratio. Interestingly, syngeneic adult PeriCre
+;Nf1
flox/2
mice were smaller than the other three groups of mice (Figure S3A).
Furthermore, PeriCre
+;Nf1
flox/2 mice had reduced body weight and
length as compared to WT, Nf1+/2,o rPeriCre
+;Nf1
flox/flox mice
(Figure S3B, C).
To investigate these skeletal phenotypes in more detail, a series
of radiographic analyses were conducted to measure BMD and
bone architecture. PeriCre
+;Nf1
flox/2 mice were shown to have
reduced whole body BMD as compared to PeriCre
+;Nf1
flox/flox, WT,
or Nf1+/2 mice (Figure 1A) measured by peripheral Dual-Energy
X-Ray Absorptiometry (pDEXA). When trabecular bone of 16-
week old mice were evaluated using micro-computed tomography
(mCT), the bone volume (BV/TV) was similar in WT, Nf1+/2,
and PeriCre
+Nf1
flox/flox mice, while PeriCre
+Nf1
flox/2 mice exhibited
an ,23% reduction as compared to the other three genotypes
(Figure 1B–C).
PeriCre
+;Nf1
flox/2 mice have increased osteoclasts,
reduced osteoblast formation, and altered bone turnover
in vivo
Biochemical markers of bone turnover are indicative of the
overall bone metabolism and provide additional information
besides the measurement of BMD [40]. Therefore, we evaluated
the osteoclast activity in the trabecular bone of the four genotypes
of mice by tartrate-resistant acid phosphatase (TRACP) staining
and scoring the TRACP
+ osteoclasts surface (OcS) in the tibial
trabeculae over trabecular bone surface (BS). A significantly
greater OcS/BS ratio in the trabecular bone was observed in
Nf1+/2 and PeriCre
+;Nf1
flox/2 mice than WT and PeriCre
+;Nf1
flox/flox
mice as shown qualitatively and quantitatively in Figure 2A and
Figure 2B, respectively. Furthermore, PeriCre
+;Nf1
flox/2 mice had
significantly higher serum levels of TRACP5b compared to WT
mice (1.26 unit60.06 vs. 1.82unit60.10, respectively, p,0.005)
as measured by ELISA, suggesting an increased osteoclast
development in vivo. In addition, a significantly lower number
of osteoblasts was observed in Nf1+/2,P e r i C r e
+;Nf1
flox/flox and
PeriCre
+;Nf1
flox/2 mice compared to WT mice, as evaluated by
counting osteoblasts in tibial trabecular bone on MacNeal’s
stained sections (Figure 2C–D). Interestingly, PeriCre
+;Nf1
flox/2
mice had reduced osteoblast numbers in comparison to
PeriCre
+;Nf1
flox/flox mice given that both genotypes of mice had a
similar genetic background in mesenchymal-osteoblast lineage.
This suggests an additional effect of the haploinsufficient
hematopoietic microenvironment on the skeletal deficits in
PeriCre
+;Nf1
flox/2 mice in vivo.
Labeling bones with fluorochrome markers provides a means to
study the dynamic changes of bone formation [41]. Thus, we
examined bone remodeling in the four genotypes of mice using
fluorescent labeling. There was a 30% reduction in mineralizing
surface (MS/BS), a 20% reduction in mineral apposition rate
(MAR), and a 50% reduction in bone formation rate (BFR/BS) in
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PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e24917Figure 1. Loss of Nf1 results in reduced bone mineral density (BMD), volume (BV), and trabecular architecture in vivo. (A) pDEXA scans
on 4–6-month-old mice revealed a 22% reduction of whole body BMD in PeriCre
+;Nf1
flox/2 mice as compared to the other 3 genotypes of mice (n$9/
group, * and ** P,0.05). (B) mCT scans through the distal femur of 16-wk old mice revealed a significant reduction of trabecular bone volume in the
PeriCre
+;Nf1
flox/2 mice. The anterior portion of each femur had been removed for the metaphyseal architecture analysis. Red arrows indicate the
deficiency in the trabecular network in the PeriCre
+;Nf1
flox/2 mice vs. controls. (C) Quantitation of the trabecular bone volume reveals an ,22%
reduction of bone volume per unit total volume (BV/TV) in the distal femoral metaphysis of PeriCre
+;Nf1
flox/2 mice as compared to the other
genotypes (n=4–6/group, * and ** P,0.05).
doi:10.1371/journal.pone.0024917.g001
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+;Nf1
flox/2 mice in comparison to control mice (Figure 3A–
D). Together, these data suggest that PeriCre
+;Nf1
flox/2 mice had a
significant reduction in bone turnover in comparison to WT,
Nf1+/2,o rPeriCre
+;Nf1
flox/flox mice. The observation that skeletal
phenotypes manifest in adult PeriCre
+;Nf1
flox/2 mice, but not
PeriCre
+;Nf1
flox/flox or Nf1+/2 mice, suggests that the development
of skeletal defects requires nullizygous loss of Nf1 in MSCs/
osteoblasts and haploinsufficient loss of Nf1 in other cell lineages.
PeriCre
+;Nf1
flox/2 mice have delayed fracture healing
Approximately 3% of young children with NF1 acquire
pseudoarthrosis [42]. To assess whether the fracture healing
process is altered in PeriCre
+;Nf1
flox/2 mice, we induced three point
bending fractures in the control and experimental mice. WT mice
healed 28 days after the fracture as evaluated by X-ray (data not
shown) and histological analysis following H&E, Masson Tri-
chrome, McNeal staining and TRACP/Von Kossa staining
(Figure 4 A, B). In contrast, only 15% of PeriCre
+;Nf1
flox/2 mice
had healed fractures after 28 days. While WT mice had a normal
architecture in the fractured tibia, Nf1+/2 and PeriCre
+;Nf1
flox/2
tibias showed deficient trabecular and cortical bone formation and
increased osteoclasts in the callus site and impairment was most
severe in Peri
Cre+;Nf1
flox/2 mice (Figure 4A, B). These data are
summarized in Figure 4C. To evaluate whether the fractures in
PeriCre
+;Nf1
flox/2 mice are delayed in healing or non-union, the
fracture healing time was extended to 8 weeks after the fractures.
As shown in Figure 4C, 33% of the PeriCre
+;Nf1
flox/2 mice
withstood the non-unioned fractures at the end of 8-weeks.
Col2.3Cre
+;Nf1
flox/2 mice have reduced bone mineral
density (BMD) and reduced bone volume
Since the expression of periostin Cre is in both MSCs and
osteoblasts, we sought to establish whether Nf1 deficiency,
specifically in the osteoblast lineage, would result in similar
phenotypic skeletal manifestations. Conditional bi-allelic deletion
of Nf1 in osteoblasts was achieved by genetic intercross of Nf1
flox/flox
mice with Col2.3Cre+ mice, placing the Cre gene under the control
of the 2.3-kb proximal fragment of the a1(I)-collagen promoter,
which is specifically expressed in osteoblasts [33,43]. All genotypes
of mice, including WT, Nf1+/2, Col2.3Cre
+;Nf1
flox/flox , and
Col2.3Cre
+;Nf1
flox/2 mice, were born at the expected Mendelian
ratio. Similar to PeriCre
+;Nf1
flox/2 mice, syngeneic adult Col2.3-
Cre
+;Nf1
flox/2 mice displayed an ,20% reduction in body weight
and a 10% reduction in body length as compared to WT, Nf1+/2,
or Col2.3Cre
+;Nf1
flox/flox mice (data not shown). To investigate these
skeletal phenotypes in more detail, a series of radiographic
analyses were conducted to measure BMD and bone architecture.
At 8 weeks of age, Col2.3Cre
+;Nf1
flox/2 mice had an ,10%
reduction in tibial BMD as compared to WT, Nf1+/2,o r
Col2.3Cre
+;Nf1
flox/flox mice (Figure 5A) as measured by pDEXA. At
24 weeks of age, Nf1+/2 tibiae showed a 13% reduction in BMD
as compared to WT control mice. Yet, an even greater reduction
of 22% in BMD was observed in tibiae of Col2.3Cre
+;Nf1
flox/2 mice
compared to WT mice (Figure 5B). However, no significant
reduction of tibial BMD was found in Col2.3Cre
+;Nf1
flox/flox mice as
compared to WT controls.
To compare the trabecular bone volume and architecture of
long bone between the four mouse genotypes, micro-computed
tomography (mCT) analysis was performed. Col2.3Cre
+;Nf1
flox/2
mice exhibited an ,23% reduction in bone volume fraction (BV/
TV) as compared to the WT and Col2.3Cre
+; Nf1
flox/flox mice
(Figure 5C–D). Nf1+/2 mice exhibited an ,16% reduction in
BV/TV as compared to WT and Col2.3Cre
+; Nf1
flox/flox mice. This
reduced bone volume in Col2.3Cre
+; Nf1
flox/2 and Nf1+/2 mice is
consistent with the reduction of BMD in these mice.
Col2.3Cre
+;Nf1
flox/2 mice have increased osteoclast
formation and reduced osteoblast number in vivo
We next identified osteoclasts in the distal femoral metaphysis
by TRACP staining and scored the ratio of osteoclast surface over
trabecular surface of each femur as a measure of osteoclast activity.
Interestingly, a significantly greater CS/BS ratio in the trabecular
bone was observed in Nf1+/2 and Col2.3Cre
+;Nf1
flox/2 mice as
compared to WT and Col2.3Cre
+;Nf1
flox/flox mice (Figure 5E–F).
The significant difference in CS/BS ratio was even more dramatic
in Col2.3Cre
+;Nf1
flox/2 mice. In addition, a significantly lower
osteoblast number per millimeter trabecular bone surface was
observed in Nf1+/2, Col2.3Cre
+;Nf1
flox/flox and Col2.3Cre
+;Nf1
flox/2
mice as compared to WT mice (Figure 5G–H). Interestingly,
Col2.3Cre
+;Nf1
flox/2 mice had lower osteoblast number than
Col2.3Cre
+;Nf1
flox/flox mice, even though both genotypes had
identical Nf1 alleles in the osteoblast lineage, suggesting the
potential of an additional effect of the haploinsufficient hemato-
poietic microenvironment on bone formation in vivo.
Nf1+/2 bone marrow transplantation impairs fracture
healing in Nf1
flox/flox;PeriCre+ mice
To formally test the hypothesis that the hematopoietic
microenvironment has a key role in fracture healing in
PeriCreNf1
flox/flox mice, bone marrow mononuclear cells
(BMMNCs) from either WT or Nf1+/2 donor mice, that also
expressanEGFPtransgene,weretransplantedintoPeriCre
+;Nf1
flox/2,
PeriCre;Nf1
flox/flox recipient mice that had been previously treated
with ionizing radiation [31]. The hematopoietic reconstitution was
verified with flow cytometric analysis demonstrating that the
reconstituted mice had .95% EGFP positive donor bone marrow
cells and clonogenic myeloid progenitors (Figure S4). To clarify
whether the donor mesenchymal stem cells were reconstituted in the
recipient bone marrow, we cultured CFU-F using the recipient bone
marrow cells. Two weeks later, we scored the CFU-F under the
fluorescent microscope. All the CFU-Fs were negative in GFP,
suggesting the mesenchymal stem cells were originated from
recipients, but not the donor cells. This data indicated that the
donor hematopoietic cells are key for the skeletal changes in the
recipient mice.
To determine whether the transplantation of Nf1+/2 bone
marrow cells to PeriCre
+;Nf1
flox/flox mice alters fracture healing, all
the recipient mice underwent 3-point bending fracture and the
fracture healing process was investigated. Reconstitution with
Nf1+/2 BMMNCs resulted in a significant reduction in BV/TV
as assessed by mCT (Figure 6 B–C). In addition, the fracture
healing in PeriCre;Nf1
flox/flox mice transplanted with Nf1+/2
Figure 2. PeriCre
+;Nf1
flox/2 mice have increased osteoclasts and decreased osteoblasts in vivo. (A) TRACP staining revealed a significant
increase of osteoclasts in PeriCre
+;Nf1
flox/2 mice. Representative photomicrographs shows TRACP+ osteoclasts in tibia of each mouse genotype (Red
staining are TRACP positive osteoclasts). (B) Quantitative data showing the change of surfaces/BS ratio. ***P,0.001 for Nf1+/2 and PeriCre
+; Nf1
flox/2
VS WT controls. (C) Representative photomicrograph showing MacNeal staining of the tibia of each mouse genotype (Red arrow heads are pointing
to osteoblasts). (D) Quantitative data showing the osteoblast number in trabecular bone/ mm BS. ***P,0.001 for . WT control vs PeriCre
+;Nf1
flox/2 ,
Nf1+/2 and PeriCre
+;Nf1
flox/flox mice.
doi:10.1371/journal.pone.0024917.g002
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bone marrow cells. This impaired fracture healing was confirmed
by histological analysis (Figure 6D), which revealed that transplan-
tation of Nf1+/2, but not WT BMMNCs, led to impaired fracture
healing (Figure D). Similar results were obtained in a parallel study
using Nf1+/2 BMMNCs transplanted into Nf1
flox/lfox;Col2.3Cre+
recipients (Figure 6E). Most importantly, transplantation of WT
BMMNCs restored the fracture healing of Nf1
flox/l2;PeriCre+
recipients (Figure 6 A–D) and Nf1
flox/2;Col2.3Cre+ recipients
(Figure 6E). Collectively, these data indicate that the haploinsuffi-
cient bone marrow microenvironment plays an essential role in the
skeletal manifestations of NF1, particularly in fracture non-union.
Discussion
Although skeletal manifestations collectively affect up to 50% of
NF1 patients [44,45,46,47], the cellular mechanism(s) underlying
the development of skeletal defects in NF1 patients are
incompletely characterized. Previous attempts using other murine
models have identified single lineage and phenotypic alterations
that do not fully recapitulate the pathological phenotypes observed
in individuals with NF1 [32,33,48,49]. The genetic intercrosses
conducted in the present study provide novel murine models
(PeriCre
+;Nf1
flox/2 mice and Col2.3Cre
+;Nf1
flox/2 mice ) that closely
recapitulate multiple skeletal phenotypes observed in NF1 patients,
particularly the pathological non-union of fractures affecting
young children.
In the present study, we generated two novel murine models
using Cre-mediated recombination under the direction of either
the MSC/osteoblast-selective periostin fragment promoter or the
osteoblast-specific Col2.3 Cre promoter. In these mice, one Nf1
allele was systemically deleted from all tissues (global knockout),
while the remaining allele was conditionally deleted in mesenchy-
mal stem/progenitor cells and/or osteoblasts. The two models
allow us to compare the impact of the deficiency of Nf1 at different
stages during MSC and osteoblast development of the skeletal
deficits. PeriCre
+;Nf1
flox/2 mice and Col2.3Cre
+;Nf1
flox/2 mice show
increased osteoclast development compared to control mice in vivo.
In addition, these mice display reduced bone mineral density
(BMD) and impaired fracture healing compared to control mice.
Recent studies have begun to elucidate the interactions between
haploinsufficient and nullizygous Nf1 cells within the slow growing
tumors found in individuals with NF1. Consistent with Nf1 being a
tumor suppressor gene, Zhu, et al have shown that nullizygosity of
Nf1 in the tumorigenic Schwann cell is required for plexiform
neurofibroma progression [15]. However, in this model which
results in a small fraction of Nf12/2 Schwann cells that likely
appear analogous to the human situation, haploinsufficiency in
non-tumorigenic lineages is also required [15]. Furthermore,
Daginakatte, et al. have shown a similar phenomenon in optic
gliomas in the NF1 murine model [13,14]. Recently, we reported
that haploinsufficiency of Nf1 in the hematopoietic microenviron-
ment specifically has a critical role in plexiform neurofibroma
formation [12]. Thus, while there is a structural framework that
explains the development of slow growing tumors in NF1 patients,
no such pathogenic framework to explain the genesis of non-
malignant conditions exists. In the present study, we showed that
the full development of skeletal manifestations in the NF1 murine
model requires both the loss of Nf1 in osteoblast precursors/
osteoblasts and the haploinsufficiency of Nf1 in the hematopoietic
microenvironment. This data is consistent with a single case report
by Stevenson and colleagues who found that localized nullizygous
loss of NF1 in pseudarthrosis tissue is acquired by micro-dissection
and NF1 haploinsufficiency in peripheral blood [29].
Given that our adoptive transfer study indicates that the Nf1
haploinsufficient bone marrow cells are important for non-union
to occur and WT bone marrow cells restores fracture healing,
these observations lead to opportunities of clinical and therapeutic
significance. Here, we show that PeriCre
+;Nf1
flox/2 mice trans-
planted with Nf1+/2, but not WT bone marrow, exhibit impaired
fracture healing. Most importantly, WT transplantation of bone
marrow restored fracture healing of PeriCre
+;Nf1
flox/2 and
Col2.3Cre
+;Nf1
flox/2 mice. We previously reported a key role for
Nf1 haploinsufficiency in the elevated bone resorptive activity in
both murine and human NF1 osteoclasts [31]. This lineage is likely
the key effector of the microenvironment. To our knowledge, this
study provides the first evidence of a non-cell autonomous
mechanism for the pathologic development of non-malignant
NF1 pathologic manifestations. As such, these models provide an
excellent platform to further study the cellular and molecular
mechanism(s) underlying skeletal manifestations in NF1 patients.
Future research investigating the specific lineage and molecular
targets in the microenvironment that are critical for the non-union
fracture healing in NF1 is necessary.
Collectively, these data demonstrate a critical role of the
hematopoietic microenvironment in fracture healing in the NF1
population. Our study provides strong evidence of a non-cell
autonomous mechanism for the skeletal manifestations of NF1 and
demonstrates that the hematopoietic microenvironment is instru-
mental for bone loss and impaired fracture healing process.
Methods
Ethics statement
Animal care and experiments were conducted according to the
guidelines established by the Indiana University Animal Care and
Use Committee (IACUC). This study was approved by IACUC
via Protocol Number 0000003401 originally approved on 6/19/
09.
Animals
Nf1+/2 mice were obtained from Dr. Tyler Jacks at the
Massachusetts Institute of Technology (Cambridge, MA) [50].
Nf1
flox/flox mice were provided by Dr. Luis Parada at the University
of Texas Southwestern Medical Center [15]. 3.9kb
peri-EGFP/Cre
(PeriCre) transgenic mice were generated as described elsewhere
[38,51]. To examine the lineage distribution of Cre-Mediated
recombination, adult PeriCre transgenic mice were crossed with
ROSA26 reporter mice. Col2.3Cre transgenic mice were generated
as described elsewhere [52]. All studies were approved by the
Institutional Animal Care and Use Committee.
Histochemical detection of b-gal activity
To examine the Cre recombinase expression pattern in MSC
and skeletal tissues, LacZ expression was determined as described
previously [52]. Histochemical detection of b-gal activity was
Figure 3. Loss of Nf1 results in reduced bone turnover in vivo. (A) Representative photomicrographs showing the uptake of calcein and
alizarin fluorochromes into newly mineralizing bone. (B) Quantification of the proportion of the total trabecular surface that was actively engaged in
bone mineralization (MS/BS). (C) The radial rate of bone deposition at active sites (MAR) is shown. (D) The total rate of newly forming bone (BFRBS/
year) was calculated and shown.
doi:10.1371/journal.pone.0024917.g003
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and tibiae of PeriCre
+;Nf1
flox/2;Rosa
flox/flox mice and PeriCre
2;
Nf1
flox/2;Rosa
flox/flox mice. Tissues/cells were fixed for 3 hours in
a 0.1 M sodium phosphate buffer (PBS, pH 7.3) containing 0.2%
gluteraldehyde, 5 mM EGTA, and 2 mM magnesium chloride.
Following 3 wash cycles with a buffer containing 0.1 M PBS,
Figure 4. PeriCre
+;Nf1
flox/2 mice have a delayed fracture healing process. (A) H&E staining (upper and middle panels 1–4, 5–8) and Masson
Trichrome staining (lower panels10–12). (B) McNeal/von Kossa staining (upper panels1–4), TRACP/Von Kossa (middle panels 5–8), and Alcian blue
staining (lower panels 9–12) of the tibia 4 weeks after the fracture. (C) Percent of healed fractures at a series of time points.
doi:10.1371/journal.pone.0024917.g004
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PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e24917Figure 5. Loss of Nf1 results in reduced bone mineral density (BMD), volume (BV), and trabecular architecture in Col2.3Cre
+;Nf1
flox/2
mice in vivo. BMD was measured with pDEXA scans at 8 weeks (A) (*p,0.05) and 24 weeks (B) (*p,0.05, **p,0.01). WT (n=12), Nf1+/2 (n=10),
Col2.3Cre
+;Nf1
flox/flox (n=12), and Col2.3Cre
+;Nf1
flox/2 (n=11). (C) Micro-CT (mCT) scans were performed on the distal femurs of 4 month old WT (n=5),
Nf1+/2 (n=5), Col2.3Cre
+;Nf1
flox/flox (n=5) and Col2.3Cre
+;Nf1
flox/2 (n=5) mice. Representative reconstructed 3D pictures are shown. The anterior
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NonidetP40, tissues/cells were incubated for 4 hours at 37uC with
b -gal staining solution containing 50 mg b -gal (Sigma Chemical
Company, St. Louis, MO, USA), 0.106 g potassium ferrocyanide,
and 0.082 g potassium ferricyanide in 50 ml wash buffer. After the
staining, tissues/cells were washed 3 times with PBS and placed
overnight in 10% formalin. The samples were then decalcified
with 14% EDTA and embedded in paraffin. 6 mm thick sections
were stained for LacZ with a hematoxylin counterstain.
Longitudinal in vivo peripheral dual-energy X-ray
absorptiometry (pDEXA)
To evaluate the bone mass in each genotype of mice, bone
mineral density (BMD) of the tibial diaphysis was evaluated in vivo
using pDEXA (PIXImus II; GE-Lunar Corp., Madison, WI) [48].
Adult mice were anesthetized via inhalation of 2.5% isoflurane
(IsoFlo; Abbott Laboratories, North Chicago, IL) mixed with O2
(1.5 liter/min). The mice were placed in a prone position on the
specimen tray and scanned. The head was excluded from total
body scans. The region of interest included the central 50% of the
whole tibia.
Micro (m) computed tomography
Bone volume and microarchitecture in the distal femoral
metaphysis were evaluated using a high-resolution desktop
microcomputed tomography imaging system (mCT-20; Scanco
Medical AG, Basserdorf, Switzerland). For evaluation of the
trabecular envelope at the distal femoral metaphysis, each
specimen was scanned with a slice increment of 9 mm. CT images
were reconstructed, filtered (s=0.8 and support=1.0), and
thresholded (22% of maximum possible gray scale value) as
previously described [53]. Scanning for the femur was started at
15% of the total femur length measured from the tip of the femoral
condyle and extended proximally for 200 slices. The area for
trabecular analysis was outlined within the trabecular compart-
ment, excluding the cortical and subcortical bone. Every 10
sections were outlined manually, and the intermediate sections
were interpolated with the contouring algorithm to create a
volume of interest. Parameters of microarchitecture for both
skeletal sites included bone volume (BV, mm
3) and bone volume
fraction (BV/TV, %), as well as trabecular number (Tb.N, mm
21),
trabecular thickness (Tb.Th, mm), and trabecular separation
(Tb.Sp, mm).
Fluorochrome bone labeling and histomorphometric
measurements
Fluorochrome labeling of the bones was performed in 8 week-
old mice by intraperitoneal injections of calcein (20 mg/kg, Sigma
Chemical, St. Louis, MO, USA) and alizarin (20 mg/kg, Sigma) 8
and 3 days before sacrifice, as previously described [54]. After
sacrifice, femurs were fixed in 10% neutral buffered formalin
for 48 hours, dehydrated in graded ethanols, and embedded
undecalcified in methylmethacrylate. Frontal sections (4 mm thick)
were cut from the distal femur using a motorized microtome
equipped with a tungsten-carbide knife (Leica Inc, Deerfield Il).
The sections were reacted with tartrate-resistant acid phosphatase
(TRACP) for identifying and measuring the osteoclast surface or
mounted unstained for fluorochrome-derived bone formation
parameters. One section per tibia was viewed at 1606
magnification on a Leitz DMRXE microscope (Leica Mikroskopie
und System GmbH, Wetzlar, Germany) and the image captured
using a SPOT digital camera (Diagnostic Instruments, Inc.,
Sterling Heights, MI). The measurement area for the distal
femoral metaphysis was determined by a region beginning 0.5 mm
proximal to the midpoint of the growth plate, non-inclusive of
cortical bone, and extending proximally for a total area of
approximately 2.8 mm
2. Trabecular bone turnover was assessed
by measuring the extent of single label (sL.Pm), double label
(dL.Pm) and the area of bone (dL.Ar) between the calcein and
alizarin labels using Image Pro Plus version 4.1 software (Media
Cybernetics, Silver Spring, MD). Derived histomorphometric
parameters included mineralizing surface (MS/BS, %), a measure
of active bone-forming surface, calculated as follows: the [K
sL.Pm+dL.Pm]/Tt.Pm * 100; mineral apposition rate (MAR, mm/
day), a measure of the rate of radial expansion of new bone,
calculated as follows: dL.Ar/dL.Pm/4 dy; and bone formation
rate, an overall measure of bone formation that combines MS/BS
and MAR, calculated as follows: MS/BS * MAR * 3.65.
For histological analysis of cell populations, after sacrifice, tibiae
were dissected from the mice and were fixed in 10% neutral
buffered formalin for 48 hours, dehydrated in graded ethanols,
and embedded undecalcified in methylmethacrylate. Frontal
sections (4 mm thick) were cut from the tibiae using a motorized
microtome equipped with a tungsten-carbide knife (Leica Inc,
Deerfield Il). The sections were reacted with TRACP for
identification and measuring of osteoclast surface. MacNeal and
/or von Kossa staining were utilized for identifying osteoblasts and
calcified bones. The sections were viewed at 2006magnification
on a Leitz DMRXE microscope (Leica Mikroskopie und System
GmbH, Wetzlar, Germany) and the images were captured using a
SPOT digital camera (Diagnostic Instruments, Inc., Sterling
Heights, MI). The quantification of osteoblast cell number and
osteoclast surface were normalized to the bone surface in
millimeters (mm), to control for the total amount of trabecular
bone surface within each histological section.
Generation of fracture and X-ray scan
A single tibial fracture was induced as described previously
[55,56,57]. With the animal lying supine on the operating table,
an intramedullary rod (a 30-G needle) was surgically inserted via
the proximal end of the tibiae into the medullary canal of the tibia,
so as to stabilize the bone post-fracture and permit load-bearing. A
200-gram weight was dropped from a height of 30-cm to fracture
the tibia between the middle to lower 1/3 of the bone. Mice were
X-rayed following the fracture to verify standardization of the
portion of each femur has been removed for the metaphyseal architecture analysis. Deficiencies in the trabecular network are indicated by the red
arrows. (D) Quantitation of 3D reconstruction and BV/TV ratio analysis. Trabecular bone formation is decreased in both Nf1+/2 (*p,0.05) and
Col2.3Cre
+;Nf1
flox/2 (**p,0.01) mice as compared to WT and Col2.3Cre
+;Nf1
flox/flox mice. Four month old WT (n=5), Nf1+/2 (n=5), Col2.3Cre
+;Nf1
flox/flox
(n=5), and Col2.3Cre
+; Nf1
flox/2 (n=5) mouse femur samples were processed for analysis. TRACP staining (E, F) and MacNeals’ staining (G, H) were
performed. (E) Representative photographs of the trabecular bone following TRACP staining (upper panel 46and lower panel 206) are shown. The
red stained area indicates osteoclasts. (F) Quantitative analysis showing the change of osteoclast surface per bone surface. ***p,0.0001 as analyzed
by ANOVA and Bonferroni’s Multiple Comparison Test. (G) Representative photomicrographs (upper panel 46and lower panel 206) are shown. Light
pink staining represents bony tissue (trabecular spicules). Blue staining represents the marrow cavity and includes bone marrow cells. Red arrow head
are pointing to osteoblasts. (H) Quantitative data of osteoblast number over bone surface. One-way ANOVA analysis and Bonferroni’s Multiple
Comparison Test were used to evaluate statistical significance of the results. ***p,0.0001.
doi:10.1371/journal.pone.0024917.g005
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flox/flox and Col2.3Cre; Nf1
flox/flox mice. (A) Lethally irradiated
PeriCre; Nf1
flox/flox and PeriCre; Nf1
flox/2 mice were transplanted with Nf1+/2 or WT bone marrow and monitored until 4 months following the
transplantation. Tibia bone mineral density was measured 4 months after bone marrow transplantation (***p,0.0001). Mice then underwent tibial
fracture four weeks before sacrifice. The genotypes are indicated. (B) 3-D reconstruction photographs from mCT scans of the fractured tibias. (C)
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then placed in recovery cages. Fracture repair was monitored by
weekly radiography (pixRay-100, Bioptics, Phoenix, AZ) and cases
where the internal fixation failed, (due to pin slippage, bending or
breakage) the affected mouse was euthanized and excluded from
subsequent analysis.
MSC and committed osteoprogenitor culture in murine
specimens
MSCs were generated from each experimental group of mice
as previously described [49]. Briefly, BM mononuclear cells
(BMMNCs) were separated by low density gradient centrifugation
from 6,8-week old mice. BMMNCs were then resuspended and
cultured in mouse MesenCult basal medium containing MesenCult
Supplement (Stem Cell Technologies Inc.) at a concentration of
2610
6 cells/mL in a 10-cm tissue culture plate as previously
described. When the cultures reached 80–90% confluency, cells
were trypsinized and replated at a concentration of 5610
5 cells/
75 cm
2.M S C sa tp a s s a g e5t o1 0w e r eu s e df o rt h ef o l l o w i n g
experiments. To culture committed osteoprogenitors, calvaria or
femur distal metaphyses were resected and chopped finely with a
scalpel. Bone chips were exposed to 0.25% trypsin for 1 hour and
then passed through a 70-mm cell strainer (Falcon, Franklin Lakes,
NJ,USA)toremovedebrisandmatrixremnants.Cellswerecultured
in a-MEM medium and supplemented with 10% fetal bovine serum
(FBS) and 1% penicillin–streptomycin at 37uC, 5% CO2.
Bone marrow transplantation of hematopoietic cells
10
6 syngeneic WT or Nf1+/2 bone marrow cells from WT
GFP or Nf1+/2 GFP mice were transplanted into young adult
PeriCre;Nf1
flox/flox recipient mice following 1100 rads of ionizing
radiation with two split doses [12]. The C57BL/6-TgN(ACT-
bEGFP) 1Osb transgenic mouse line was obtained from Jackson
Laboratory, Bar Harbor, Maine [58].
Statistical analysis. One way ANOVA and post t-test was used
for all the statistical analysis in this study. P values less than 0.05
are considered as statistically significant.
Supporting Information
Figure S1 PeriCre is specifically expressed in the
skeletal tissues of adult PeriCre transgenic mice. (A)
Four-week old PeriCre transgenic (b,d) or control (a, c) mice were
dissected and fixed in 4% paraformaldehyde. The whole bodies
were washed in b-gal buffer 3615 minutes at 4uC and then
overnight with shaking. After a final wash in b-gal buffer, the
whole bodies were stained with b-gal substrate at 37uC for 3 hrs.
Periostin-Cre expression is reflected by blue LacZ staining.
Representative cross sections from LacZ staining with H&E
counterstaining are shown. PeriCre expression is reflected by blue
staining. (B) Osteoblast cell cultures were prepared by digestion of
the calvaria and incubated in alpha-MEM medium supplemented
with 10%FBS, ascorbic acid, b-galactophospate, and dexathamo-
sone. MSCs were prepared from bone marrow mononuclear cells.
The cells were fixed in 4% paraformaldehyde in PBS and washed
in b-gal buffer 3615 minutes at 4uC. Cells were stained in b-gal
substrate at 37uC for 3 hours. Blue staining represents LacZ
positive osteoblasts or MSCs. (C) Neurofibromin expression in
WT, Nf1+/2, and Nf12/2 MSCs and calvarial osteoblasts
evaluated by western blot.
(TIF)
Figure S2 PCR of tail DNA. Differential expression of Nf1,
PeriCre, Loxp, and recombinant Cre was confirmed by PCR.
(TIF)
Figure S3 PeriCre
+;Nf1
flox/2 mice exhibit reduced body
size and weight. (A) Photographs of representative 4 month old
mice from each genotype. (B) Body length was measured from the
snout to the proximal end of the tail in 4 month old mice of each
genotype. The number of animals analyzed were WT, n=24;
Nf1+/2, n=20; PeriCre
+;Nf1
flox/flox, n=27; PeriCre
+;Nf1
flox/2,
n=48. (C) Quantitative data of body weight of 4-month old mice
of each genotypes.
(TIF)
Figure S4 The donor cells are presented in recipient mice. (A)
Flow cytometric analysis of peripheral blood shows more than
95% cells are GFP positive. Colonies were observed under light
microscope and fluorescent microscope. 100% of colonies are GFP
positive. (B) Individual colonies were picked up from methylcel-
lulose cultures and were subjected to PCR analysis.
(TIF)
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